Cargando…

Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome

Segmental progeroid syndromes are commonly represented by genetic conditions which recapitulate aspects of physiological aging by similar, disparate, or unknown mechanisms. Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disease caused by mutations in the gene for ACVR1/ALK2 encoding A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pignolo, Robert J., Wang, Haitao, Kaplan, Frederick S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966325/ https://www.ncbi.nlm.nih.gov/pubmed/31998237 http://dx.doi.org/10.3389/fendo.2019.00908

Ejemplares similares

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)
por: Hsiao, Edward C., et al.
Publicado: (2018)

Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
por: Pignolo, Robert J, et al.
Publicado: (2011)

Compartment Syndrome of the Thigh in a Patient with Fibrodysplasia Ossificans Progressiva
por: Kaplan, Frederick S., et al.
Publicado: (2020)

Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization
por: Pignolo, Robert J., et al.
Publicado: (2021)

Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective
por: Pignolo, Robert J., et al.
Publicado: (2022)

OR29-05 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 12-Month Outcomes
por: Mukaddam, Mona Al, et al.
Publicado: (2020)

PSAT180 Fibrodysplasia Ossificans Progressiva (FOP) A Case Series
por: Almonaei, Khulod, et al.
Publicado: (2022)

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial
por: Pignolo, Robert J., et al.
Publicado: (2022)

Clinical, evolution and therapeutical considerations upon a case of fibrodysplasia ossificans progressiva (FOP)
por: Rogoveanu, O, et al.
Publicado: (2013)

Fibrodysplasia ossificans progressiva
por: Smit, Chané, et al.
Publicado: (2023)

Crohn's Disease in a Patient With Fibrodysplasia Ossificans Progressiva
por: Havlichek, Daniel, et al.
Publicado: (2022)

Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022)

Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
por: Padilha, Elias C., et al.
Publicado: (2019)

Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles
por: Eekhoff, Elisabeth M.W., et al.
Publicado: (2022)

The Developmental Phenotype of the Great Toe in Fibrodysplasia Ossificans Progressiva
por: Towler, O. Will, et al.
Publicado: (2020)

Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis
por: Kaplan, Frederick S., et al.
Publicado: (2012)

Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases
por: Baujat, Geneviève, et al.
Publicado: (2017)

Radiotherapy in Fibrodysplasia Ossificans Progressiva: A Case Report and Systematic Review of the Literature
por: Botman, Esmée, et al.
Publicado: (2020)

Longitudinal Evaluation of Pain, Flare‐Up, and Emotional Health in Fibrodysplasia Ossificans Progressiva: Analyses of the International FOP Registry
por: Peng, Ke, et al.
Publicado: (2019)

Recent Topics in Fibrodysplasia Ossificans Progressiva
por: Katagiri, Takenobu, et al.
Publicado: (2018)

Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis
por: De Brasi, Daniele, et al.
Publicado: (2021)

Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop
por: de Ruiter, Ruben D., et al.
Publicado: (2021)

Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva
por: Pignolo, Robert J., et al.
Publicado: (2023)

Fibrodysplasia Ossificans Progressiva and Pregnancy: A Case Series and Review of the Literature
por: Forrest, Alexandra D., et al.
Publicado: (2022)

Quality of life of patients with fibrodysplasia ossificans progressiva
por: Ortiz-Agapito, Fernando, et al.
Publicado: (2015)

Bone Resection Osteotomy in Fibrodysplasia Ossificans Progressiva
por: Colmenares-Bonilla, Douglas, et al.
Publicado: (2018)

Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva
por: Khan, Fatima, et al.
Publicado: (2021)

Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes
por: Pignolo, Robert J., et al.
Publicado: (2019)

“I Can’t Take off My Shirt or Do My Own Hair”—A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP)
por: Markowitz, Jessica T., et al.
Publicado: (2022)

SUN-344 Patients with Fibrodysplasia Ossificans Progressiva Have an Increased Prevalence of Cardiac Conduction Abnormalities
por: Kou, Samuel, et al.
Publicado: (2020)

Recent progress in drug development for fibrodysplasia ossificans progressiva
por: Meng, Xinmiao, et al.
Publicado: (2022)

Correction to: Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes
por: Pignolo, Robert J., et al.
Publicado: (2019)

Fibrodysplasia Ossificans Progressiva: A Report of Four Cases
por: Elamin, Mohamed, et al.
Publicado: (2022)

Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives
por: Smilde, Bernard J, et al.
Publicado: (2022)

Limb specific Acvr1‐knockout during embryogenesis in mice exhibits great toe malformation as seen in Fibrodysplasia Ossificans Progressiva (FOP)
por: Hildebrand, Laura, et al.
Publicado: (2019)

The Diversity of the Clinical Phenotypes in Patients With Fibrodysplasia Ossificans Progressiva
por: Al Kaissi, Ali, et al.
Publicado: (2016)

Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
por: Ventura, Francesc, et al.
Publicado: (2021)

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
por: Williams, Eleanor, et al.
Publicado: (2021)

Fibrodysplasia ossificans progressiva (stone man syndrome): a case report
por: Shah, Zakir Ali, et al.
Publicado: (2019)

Superior mesenteric artery syndrome in a patient with fibrodysplasia ossificans progressiva
por: Ahn, Tae Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hqlmbn0lfgd9b5iti88esobqbj